HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregorius P M Luyten Selected Research

Uveal melanoma

7/2022Comparison of Magnetic Resonance Imaging-Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma.
12/2021Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy.
9/2021LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma.
8/2021MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3.
8/2021In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target.
1/2021Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
12/2020HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma.
10/2020Measuring eye deformation between planning and proton beam therapy position using magnetic resonance imaging.
2/2020Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study.
11/2019Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregorius P M Luyten Research Topics

Disease

25Uveal melanoma
07/2022 - 08/2002
23Neoplasms (Cancer)
07/2022 - 06/2006
14Melanoma (Melanoma, Malignant)
02/2021 - 11/2003
9Neoplasm Metastasis (Metastasis)
12/2021 - 06/2009
6Monosomy
09/2021 - 08/2012
5Cataract (Cataracts)
04/2022 - 11/2005
5Inflammation (Inflammations)
08/2021 - 11/2010
4Hyperopia (Hypermetropia)
06/2021 - 01/2003
4Myopia
04/2009 - 01/2003
4Astigmatism
07/2006 - 01/2003
3Hypoxia (Hypoxemia)
07/2019 - 05/2010
2Nevus (Nevi)
11/2020 - 08/2019
2Chromosome Aberrations (Chromosome Abnormalities)
08/2019 - 09/2015
1Vision Disorders (Hemeralopia)
12/2021
1Renal Cell Carcinoma (Grawitz Tumor)
08/2019
1Malignant Mesothelioma
08/2019
1Skin Neoplasms (Skin Cancer)
08/2019
1Meningioma (Meningiomas)
08/2019
1Cholangiocarcinoma
08/2019
1Ischemia
07/2019
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2018
1Testicular Neoplasms (Testicular Cancer)
01/2017
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2013
1Refractive Errors (Refractive Error)
10/2013
1Autoimmune Diseases (Autoimmune Disease)
05/2012
1Colonic Neoplasms (Colon Cancer)
01/2012
1Carcinoma (Carcinomatosis)
01/2012
1Macular Edema
01/2012
1Stomach Neoplasms (Stomach Cancer)
01/2012
1Sarcoma (Soft Tissue Sarcoma)
01/2012
1Hemorrhage
01/2012
1Keratoconus
11/2011

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
08/2021 - 11/2010
5Proteins (Proteins, Gene)FDA Link
08/2021 - 12/2014
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017 - 05/2010
4Messenger RNA (mRNA)IBA
08/2021 - 01/2017
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2016 - 06/2009
3Oxygen (Dioxygen)IBA
11/2020 - 01/2012
2Tumor Biomarkers (Tumor Markers)IBA
07/2022 - 11/2003
2LigandsIBA
09/2021 - 06/2009
2ChemokinesIBA
10/2012 - 08/2012
2Bevacizumab (Avastin)FDA Link
01/2012 - 01/2012
2Monoclonal AntibodiesIBA
01/2012 - 02/2011
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2006 - 02/2006
1HLA-A Antigens (HLA-A)IBA
09/2021
1Galectin 3 (LGALS3)IBA
09/2021
1HLA-B Antigens (HLA-B)IBA
09/2021
1Histone Deacetylases (Histone Deacetylase)IBA
08/2021
1MicroRNAs (MicroRNA)IBA
08/2021
1Angiopoietin-2IBA
08/2021
1Angiopoietin-1IBA
08/2021
1RNA (Ribonucleic Acid)IBA
02/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Verteporfin (Visudyne)FDA Link
01/2021
1Retinaldehyde (Retinal)IBA
11/2020
1pheomelaninIBA
09/2020
1eumelaninIBA
09/2020
1Biomarkers (Surrogate Marker)IBA
11/2019
1MMEIBA
08/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Melanins (Melanin)IBA
01/2019
1N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
11/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2018
1AntigensIBA
01/2017
1Peptides (Polypeptides)IBA
01/2016
1RutheniumIBA
11/2012
1Chemokine CCL5IBA
10/2012
1Interleukin-6 (Interleukin 6)IBA
10/2012
1Interleukin-8 (Interleukin 8)IBA
10/2012
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2012
1HLA-DR6 Antigen (HLA DR6 Antigen)IBA
05/2012
1HLA-DR Antigens (HLA-DR)IBA
05/2012
1Indicators and Reagents (Reagents)IBA
01/2012
1Angiogenesis InhibitorsIBA
01/2012
1PPAR gammaIBA
09/2010
1HLA-C Antigens (HLA-C)IBA
06/2009
1Natural Killer Cell ReceptorsIBA
06/2009
1Immunoglobulins (Immunoglobulin)IBA
06/2009
1micaIBA
06/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2008
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2008
1Octreotide (Sandostatin)FDA LinkGeneric
11/2008

Therapy/Procedure

10Phakic Intraocular Lenses
04/2022 - 01/2003
5Therapeutics
11/2021 - 04/2003
4Radiotherapy
12/2018 - 01/2012
3Proton Therapy
07/2022 - 10/2020
2Brachytherapy
01/2021 - 07/2017
2Slit Lamp
11/2018 - 09/2011
1Drug Therapy (Chemotherapy)
12/2020
1Aftercare (After-Treatment)
02/2020
1Refractive Surgical Procedures
12/2019
1Intravitreal Injections
07/2017
1Injections
07/2017
1Immunotherapy
01/2017
1Intraocular Injections
01/2012
1Contact Lenses
11/2011
1Intraocular Lenses (Intraocular Lens)
04/2009
1Vitrectomy
06/2006
1Lasers (Laser)
06/2006
1Light Coagulation
06/2006